KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for Novavax (NVAX) over the last 17 years, with Sep 2025 value amounting to $762.9 million.

  • Novavax's Cash & Current Investments fell 16.12% to $762.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 0.72%. This contributed to the annual value of $923.1 million for FY2024, which is 62.38% up from last year.
  • According to the latest figures from Q3 2025, Novavax's Cash & Current Investments is $762.9 million, which was up 24.59% from $612.3 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Cash & Current Investments registered a high of $2.1 billion during Q2 2021, and its lowest value of $480.6 million during Q1 2024.
  • For the 3-year period, Novavax's Cash & Current Investments averaged around $710.9 million, with its median value being $651.1 million (2023).
  • As far as peak fluctuations go, Novavax's Cash & Current Investments surged by 741.66% in 2021, and later crashed by 63.22% in 2023.
  • Novavax's Cash & Current Investments (Quarterly) stood at $1.5 billion in 2021, then fell by 11.76% to $1.3 billion in 2022, then plummeted by 57.48% to $568.5 million in 2023, then soared by 62.38% to $923.1 million in 2024, then declined by 16.12% to $762.9 million in 2025.
  • Its Cash & Current Investments stands at $762.9 million for Q3 2025, versus $612.3 million for Q2 2025 and $731.5 million for Q1 2025.